CYP3A4 and breast cancer: Etoposide, a semisynthetic derivative of podophyllotoxin used in BC treatment, undergoes O-demethylation to yield etoposide catechol with the involvement of CYP3A4 and, to a lesser extent, of CYP1A2 and CYP2E1 [132].